查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2094853

基因組編輯市場的突變檢測試劑盒：2026-2032年全球市場預測

Mutation Detection Kits In Genome Editing Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，基因組編輯市場的突變檢測試劑盒市場將成長至 7.4735 億美元，複合年成長率為 17.27%。

主要市場統計數據
基準年 2025 2.4492億美元
預計年份：2026年 2.8656億美元
預測年份 2032 7.4735億美元
複合年成長率 (%) 17.27%

在基因組編輯領域，突變檢測試劑盒正成為檢驗標靶編輯、識別非預期序列變化以及支持研究、臨床應用、農業和生物製造等領域品管的關鍵工具。隨著 CRISPR-Cas 系統、鹼基編輯器、先導編輯器和設計核酸酶不斷拓展基因組工程的應用範圍，對可靠的突變檢測流程的需求也日益成長。這些試劑盒通常用於錯配檢測、基於擴增子的定序預處理、限制性內切酶分析、高解析度熔解曲線分析、Sanger定序檢驗以及基於次世代定序的驗證等應用。

基因組編輯技術在功能基因體學、細胞和基因治療開發、作物性狀改良、微生物工程以及疾病模型建構等領域的日益廣泛應用，推動了市場對相關檢測方法的需求。同時，針對編輯特徵、鑑定、純度、效力以及脫靶效應評估等方面的監管要求，也提升了檢驗的檢測方法的重要性。在此背景下，實驗室優先選擇靈敏度高、可重複性好、樣品製備簡單、相容於多種物種且能與下游資料分析工具整合的突變檢測試劑盒。

基因組編輯中突變檢測格局的變革性轉變。

突變檢測試劑盒的格局正從單一檢測方法的確認轉向整合的高解析度檢驗體系。雖然傳統的凝膠電泳和酵素法檢測仍然適用於快速篩檢，但研究機構擴大將它們與定序的工作流程相結合，以提高編輯檢驗的可靠性。這種轉變反映了基因組編輯結果日益複雜，包括插入、缺失、替換、大規模排、嵌合體、對偶基因特異性編輯和低頻突變。

人工智慧對突變檢測的累積影響

人工智慧 (AI) 透過改進檢測設計、變異解讀、脫靶效應優先排序和工作流程效率，對基因組編輯中的突變檢測產生了日益顯著的影響。 AI 驅動的 RNA 設計指導工具能夠在實驗開始前預測編輯結果並識別潛在的脫靶位點，從而幫助選擇合適的檢測策略。機器學習模型也被用於解讀定序資料、區分真實突變和定序假象，以及對 CRISPR-Cas 及相關系統產生的複雜插入缺失 (indel) 模式進行分類。

區域間對全球突變檢測應用情況的關鍵見解。

亞太地區是基因組編輯研究的活躍區域，這得益於生命科學領域的大力投資、不斷擴展的生物技術基礎設施，以及中國、日本、韓國、印度、澳洲和東南亞國協豐富的學術成果。突變檢測試劑盒在該地區的應用，包括作物改良、水產養殖、感染疾病研究、再生醫學和細胞療法開發等，都為其提供了支持。中國和日本擁有先進的定序和基因組學能力，而印度和東南亞國家則透過公共研究計畫和生物技術孵化器，不斷提升其基因組編輯能力。

突變檢測試劑盒的關鍵經濟與策略群體分析

北約成員國與北美和歐洲的高所得科研體系高度重合，在這些國家，管治、生物安保治理、國防相關生物研究監管以及先進的衛生安全計劃進一步凸顯了精準突變檢測和標準化基因組編輯檢驗的重要性。在這些經濟體中，可追溯的工作流程、可重複的檢測性能和安全的資料處理至關重要，尤其是在敏感的基因組研究中。

關鍵國家對基因組編輯中突變檢測的見解

中國是基因組編輯研究領域最活躍的國家之一，CRISPR技術已廣泛應用於生物醫學、農業和工業領域。突變檢測試劑盒對於高通量編輯檢驗、低頻突變識別和脫靶效應評估至關重要。美國在突變檢測試劑盒在學術研究、生物技術、細胞和基因治療開發以及高通量功能基因組學領域的應用方面處於主導。完善的定序基礎設施和針對編輯後生物材料表徵的監管要求，為先進檢測方法的應用提供了支持。

為行業領導者提供的實用建議

產業領導者應優先開發能夠應對基因組編輯結果日益複雜性的突變檢測試劑盒，包括低頻突變、複雜編輯、嵌合體、對偶基因特異性改變和結構改變。產品策略應著重於靈敏度、可重複性和與 CRISPR-Cas、鹼基編輯、先導編輯和其他編輯平台的兼容性，同時為受監管的研究和轉化研究環境提供清晰的效能資料。

深入了解突變檢測試劑盒的調查方法

本執行摘要採用系統化的二手研究途徑編寫，重點關注檢驗的科學、監管和行業相關資訊來源。調查方法包括對基因組編輯驗證、突變檢測、脫靶分析、CRISPR篩檢、定序流程和人工智慧驅動的變異解讀等方面的同行評審文獻檢驗。此外，也參考了資訊來源。

結論

突變檢測試劑盒在基因組編輯技術的負責任發展中發揮核心作用，它們提供必要的證據來驗證預期編輯、識別非預期變化並支持可重複的實驗。隨著編輯技術變得越來越精確和複雜，檢驗要求也從基本的突變篩檢擴展到整合定序、分析、自動化和品質文件等各個方面。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 基因組編輯市場：依產品/服務分類

  • 突變檢測試劑盒
  • 試劑和耗材
  • 檢測組
  • 軟體和生物資訊學工具
  • 服務

第8章 基因組編輯市場：依技術分類

  • 高解析度熔融分析
  • 次世代定序（NGS）
  • 聚合酵素鏈鎖反應（PCR）
    • 數位PCR
    • 終點PCR
    • 即時PCR
  • 限制性片段長度多態性
  • 桑格定序
  • 叢集的、規則間隔的、短回文重複序列（CRISPR）

第9章 基因組編輯市場：依工作流程階段分類

  • 數據分析
  • 編輯後檢驗
  • 預編輯品管

第10章 基因組編輯市場：依應用領域分類

  • 農業生物技術
  • 基礎研究
  • 臨床診斷
  • 藥物發現和標靶檢驗
  • 細胞株工程
  • 藥物研發

第11章 基因組編輯市場：依最終使用者分類

  • 學術和研究機構
  • 臨床診斷檢查室
  • 合約研究組織（CRO）
  • 製藥和生物技術公司

第12章 基因組編輯市場：依分銷管道分類

  • 直銷
  • 經銷商
  • 線上發行

第13章 基因組編輯市場：按地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第14章 基因組編輯市場：依組別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第15章 基因組編輯市場：依國家分類

  • 中國
  • 美國
  • 日本
  • 印度
  • 德國
  • 英國
  • 澳洲
  • 法國
  • 韓國
  • 義大利
  • 加拿大
  • 俄羅斯
  • 巴西
  • 墨西哥
  • 西班牙

第16章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • 3B BlackBio Dx Limited
  • Agilent Technologies, Inc.
  • Amoy Diagnostics Co., Ltd.
  • Applied Biological Materials, Inc.
  • Bio-Rad Laboratories Inc.
  • Bioneer Corporation
  • Cell Signaling Technology, Inc.
  • Cellecta, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • GenScript Biotech Corporation
  • Illumina, Inc.
  • Lonza Group AG
  • Medaysis Company
  • Merck KGaA
  • Mylab Discovery Solutions
  • New England Biolabs, Inc.
  • Origene Technologies, Inc.
  • Paragon Genomics, Inc.
  • Promega Corporation
  • Qiagen NV
  • Revvity Inc.
  • Synthego Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • TransGen Biotech Co., Ltd.
  • Vazyme Biotech Co., Ltd.
Product Code: MRR-3A2E844FDB57

The Mutation Detection Kits In Genome Editing Market is projected to grow by USD 747.35 million at a CAGR of 17.27% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 244.92 million
Estimated Year [2026] USD 286.56 million
Forecast Year [2032] USD 747.35 million
CAGR (%) 17.27%

Mutation detection kits in genome editing are becoming essential tools for verifying on-target edits, identifying unintended sequence changes, and supporting quality control across research, clinical translation, agriculture, and biomanufacturing. As CRISPR-Cas systems, base editors, prime editors, and engineered nucleases continue to expand the scope of genome engineering, the need for reliable mutation detection workflows has intensified. These kits typically support applications such as mismatch detection, amplicon-based sequencing preparation, restriction enzyme analysis, high-resolution melt analysis, Sanger sequencing confirmation, and next-generation sequencing-based validation.

Demand is being shaped by the rising use of genome editing in functional genomics, cell and gene therapy development, crop trait improvement, microbial engineering, and disease model generation. Regulatory expectations around edit characterization, identity, purity, potency, and off-target assessment are also strengthening the role of validated detection approaches. In this environment, laboratories are prioritizing mutation detection kits that provide sensitivity, reproducibility, simplified sample preparation, compatibility with diverse organisms, and integration with downstream data analysis tools.

Transformative Shifts in the Genome Editing Mutation Detection Landscape

The landscape for mutation detection kits is shifting from single-assay confirmation toward integrated, high-resolution validation ecosystems. Traditional gel-based and enzyme-based assays remain valuable for rapid screening, but laboratories increasingly combine them with sequencing-enabled workflows to improve confidence in edit verification. This transition reflects the growing complexity of genome editing outcomes, including insertions, deletions, substitutions, large rearrangements, mosaicism, allele-specific edits, and low-frequency variants.

Another major shift is the movement from research-only use toward translational and regulated applications. Cell and gene therapy pipelines require robust analytical methods to characterize edited cells before downstream development, while agricultural biotechnology programs rely on mutation detection to confirm desired trait edits and support regulatory documentation. Automation, multiplexing, and digital workflow management are becoming important differentiators, particularly for laboratories handling high sample volumes. At the same time, advances in long-read sequencing, targeted deep sequencing, and single-cell analysis are expanding the ability to detect complex editing signatures that may be missed by conventional methods.

Cumulative Impact of Artificial Intelligence on Mutation Detection

Artificial intelligence is increasingly influencing mutation detection in genome editing by improving assay design, variant interpretation, off-target prioritization, and workflow efficiency. AI-enabled guide RNA design tools help researchers predict likely editing outcomes and potential off-target loci before experiments begin, which strengthens the selection of appropriate detection strategies. Machine learning models are also used to interpret sequencing data, distinguish true mutations from sequencing artifacts, and classify complex indel patterns generated by CRISPR-Cas and related systems.

The cumulative impact of AI is most visible in data-intensive workflows such as targeted next-generation sequencing, whole-genome sequencing, and high-throughput screening. Algorithms can support faster variant calling, improve signal-to-noise discrimination, and help identify rare edited alleles in mixed cell populations. AI-driven image and melt-curve analysis can also enhance interpretation in high-resolution melt assays and other screening platforms. As genome editing advances toward clinical and industrial applications, AI is strengthening reproducibility, reducing manual review burden, and supporting standardized quality control, provided that models are transparently validated and aligned with laboratory regulatory requirements.

Key Regional Insights Across Global Mutation Detection Adoption

Asia-Pacific is a highly active region for genome editing research, driven by strong life sciences investment, expanding biotechnology infrastructure, and significant academic output in China, Japan, South Korea, India, Australia, and ASEAN economies. The region's mutation detection kit adoption is supported by applications in crop improvement, aquaculture, infectious disease research, regenerative medicine, and cell therapy development. China and Japan maintain advanced sequencing and genomics capabilities, while India and Southeast Asian countries are expanding genome editing capacity through public research programs and biotechnology incubation.

Europe benefits from dense research networks, national genomics initiatives, and rigorous regulatory frameworks that emphasize safety, traceability, and reproducible validation. The European Union's research programs and national biotechnology strategies support genome editing in biomedical science, plant research, and industrial biotechnology, increasing the need for standardized mutation detection protocols. Germany, France, Italy, Spain, and the United Kingdom are particularly relevant due to their established genomics infrastructure, clinical research activity, and plant science capabilities.

North America remains one of the most mature environments for mutation detection in genome editing due to well-established biomedical research funding, advanced sequencing infrastructure, and strong activity in cell and gene therapy development. The United States and Canada have extensive academic, clinical, and contract research networks that rely on mutation detection kits for edit confirmation, off-target screening, and assay reproducibility.

Latin America is increasingly adopting genome editing technologies in agriculture, public health, and academic research. Brazil and Mexico are important contributors, particularly in plant biotechnology, animal genetics, and disease research. Mutation detection kits in the region are often used to support applied research where accessible, cost-efficient, and adaptable workflows are critical.

Africa is at an earlier but steadily developing stage, with genome editing interest concentrated in crop resilience, infectious disease research, livestock improvement, and capacity-building programs. Across African research hubs, scalable and easy-to-implement mutation detection methods are particularly important for expanding local genome editing capabilities. The Middle East is building genomics and precision medicine capacity through national health strategies, biobank initiatives, and university-linked research centers. Mutation detection kits are gaining relevance in inherited disease studies, oncology research, reproductive genetics, and biotechnology education.

Key Economic and Strategic Group Insights for Mutation Detection Kits

NATO countries overlap significantly with high-income research systems in North America and Europe, where biosafety, biosecurity governance, defense-related biological research oversight, and advanced health security programs reinforce the importance of accurate mutation detection and standardized genome editing validation. These economies typically emphasize traceable workflows, reproducible assay performance, and secure data handling for sensitive genomics research.

G7 countries show high levels of genome editing adoption due to advanced research infrastructure, established regulatory agencies, mature sequencing capabilities, and strong public funding for life sciences. Mutation detection kits are integral to academic research, therapeutic development, agriculture-focused innovation, and quality control in advanced biotechnology applications, with users placing high value on validated protocols and data-rich reporting.

BRICS economies represent a broad base of genome editing activity across biomedical science, agriculture, and industrial biology. China and India are major drivers through large research ecosystems, while Brazil and South Africa contribute to agricultural and public health applications. Russia maintains scientific capacity in molecular biology and biotechnology. Across BRICS, demand patterns are shaped by the need for scalable, adaptable mutation detection tools that support both advanced research centers and expanding laboratory networks.

The European Union is characterized by strong regulatory oversight, collaborative research funding, and emphasis on reproducible science. Within the EU, mutation detection kits are used in biomedical research, plant genome editing, industrial biotechnology, and preclinical development, with laboratories placing high value on validated workflows, documentation, quality systems, and data integrity.

ASEAN is strengthening its role in genome editing through agricultural biotechnology, infectious disease research, and expanding biomedical research capacity. Countries across the bloc are investing in university-based genomics programs and applied biotechnology, creating demand for mutation detection kits that are cost-effective, robust, and suitable for varied laboratory infrastructure. The GCC is increasingly prioritizing genomics, precision medicine, and biotechnology diversification as part of national development strategies. Mutation detection kits support research in inherited disorders, oncology, reproductive genetics, and translational medicine, particularly as regional health systems expand molecular diagnostics and genomic data initiatives.

Key Country Insights in Genome Editing Mutation Detection

China is one of the most active countries in genome editing research, with extensive use of CRISPR technologies in biomedical, agricultural, and industrial applications. Mutation detection kits are critical for high-throughput edit verification, low-frequency variant identification, and off-target assessment. The United States leads in the application of mutation detection kits across academic research, biotechnology, cell and gene therapy development, and high-throughput functional genomics. Strong sequencing infrastructure and regulatory expectations for characterization of edited biological materials support advanced assay adoption.

Japan's advanced genomics, regenerative medicine, and precision health infrastructure encourage sophisticated mutation detection workflows, while India is expanding genome editing research in crop resilience, healthcare, infectious disease biology, and biomanufacturing, where accessible detection kits support laboratory adoption. Germany combines advanced molecular biology, industrial biotechnology, and medical research infrastructure, creating demand for precise mutation confirmation workflows. The United Kingdom has a strong life sciences research base and active genome editing activity in functional genomics, regenerative medicine, and agricultural research.

Australia applies genome editing in agriculture, biomedical science, environmental research, and livestock improvement, creating demand for robust validation methods suited to diverse sample types. France maintains strong public research institutions and biotechnology activity in health, agriculture, and genomics. South Korea has strong activity in biotechnology, synthetic biology, and therapeutic research, supporting demand for accurate and efficient genome editing validation tools. Italy contributes through academic genomics, clinical research, plant science, and biotechnology programs requiring dependable mutation screening and sequencing validation.

Canada contributes through genomics networks, stem cell research, agricultural biotechnology, and clinical research programs that require reliable edit validation. Russia has established molecular biology and genetics expertise, with mutation detection supporting research in biomedical and agricultural contexts. Brazil is a major Latin American hub for agricultural biotechnology and biological research, where mutation detection is used in crop improvement, livestock genetics, and biomedical studies. Mexico is expanding genome editing applications in agriculture, biomedical research, and public health laboratories, with mutation detection kits supporting practical validation of edited plants, microbes, and disease models. Spain contributes through academic genomics, clinical research, plant science, and biotechnology programs requiring dependable mutation screening and sequencing validation.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize development of mutation detection kits that address the growing complexity of genome editing outcomes, including low-frequency variants, compound edits, mosaicism, allele-specific changes, and structural alterations. Product strategies should emphasize sensitivity, reproducibility, compatibility with CRISPR-Cas, base editing, prime editing, and other editing platforms, as well as clear performance documentation for regulated and translational research environments.

To strengthen adoption, organizations should invest in workflow integration that connects sample preparation, amplification, sequencing, variant analysis, and reporting. Assay automation, multiplexing, and user-friendly bioinformatics can reduce bottlenecks in high-throughput laboratories. Leaders should also support region-specific needs, including cost-efficient formats for emerging research markets, advanced sequencing-compatible kits for mature genomics hubs, and documentation-ready solutions for clinical and agricultural regulatory workflows.

Strategic partnerships with academic laboratories, clinical research centers, agricultural institutes, and standards-focused organizations can improve assay validation and build trust. Developers should also invest in AI-supported analytics while ensuring explainability, data security, and transparent performance benchmarking. Training resources, protocol standardization, and application-specific technical support will be essential for improving user confidence and supporting broader adoption of mutation detection kits in genome editing.

Research Methodology for Mutation Detection Kit Insights

This executive summary is developed through a structured secondary research approach focused on verified scientific, regulatory, and industry-relevant sources. The methodology includes review of peer-reviewed literature on genome editing validation, mutation detection assays, off-target analysis, CRISPR screening, sequencing workflows, and AI-assisted variant interpretation. It also draws from publicly available information released by government agencies, research institutions, standards bodies, public health organizations, and biotechnology policy sources.

The research framework evaluates technology trends, application areas, regional research activity, regulatory considerations, and adoption drivers without using market sizing, market share, or forecasting. Insights are triangulated across multiple credible source categories to improve reliability and reduce single-source bias. Regional, group, and country-level interpretations are based on observable indicators such as genomics infrastructure, research funding priorities, biotechnology programs, sequencing adoption, clinical translation activity, and agricultural biotechnology use cases. The analysis is designed to support strategic decision-making while maintaining a data-backed, non-speculative perspective.

Conclusion

Mutation detection kits are central to the responsible advancement of genome editing because they provide the evidence needed to confirm intended edits, identify unintended changes, and support reproducible experimentation. As editing technologies become more precise and more complex, validation requirements are expanding beyond basic mutation screening toward integrated sequencing, analytics, automation, and quality documentation.

Global adoption is being shaped by regional strengths in biomedical research, agricultural innovation, genomics infrastructure, and regulatory maturity. Artificial intelligence is adding further value by improving assay planning, variant interpretation, and high-throughput data analysis. For industry leaders, the strongest opportunities lie in developing reliable, scalable, and application-specific mutation detection workflows that can serve both advanced research environments and emerging biotechnology ecosystems. Success will depend on scientific credibility, workflow simplicity, transparent validation, and the ability to support increasingly sophisticated genome editing applications.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Mutation Detection Kits In Genome Editing Market, by Offering

  • 7.1. Introduction
  • 7.2. Mutation Detection Kits
  • 7.3. Reagents & Consumables
  • 7.4. Assay Panels
  • 7.5. Software & Bioinformatics Tools
  • 7.6. Services

8. Mutation Detection Kits In Genome Editing Market, by Technology

  • 8.1. Introduction
  • 8.2. High Resolution Melt Analysis
  • 8.3. Next-Generation Sequencing (NGS)
  • 8.4. Polymerase Chain Reaction (PCR)
    • 8.4.1. Digital PCR
    • 8.4.2. End Point PCR
    • 8.4.3. Real Time PCR
  • 8.5. Restriction Fragment Length Polymorphism
  • 8.6. Sanger Sequencing
  • 8.7. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)

9. Mutation Detection Kits In Genome Editing Market, by Workflow Stage

  • 9.1. Introduction
  • 9.2. Data Analysis
  • 9.3. Post Editing Validation
  • 9.4. Pre Editing Quality Control

10. Mutation Detection Kits In Genome Editing Market, by Application

  • 10.1. Introduction
  • 10.2. Agricultural Biotechnology
  • 10.3. Basic Research
  • 10.4. Clinical Diagnostics
  • 10.5. Drug Discovery & Target Validation
  • 10.6. Cell Line Engineering
  • 10.7. Therapeutic Development

11. Mutation Detection Kits In Genome Editing Market, by End User

  • 11.1. Introduction
  • 11.2. Academic And Research Institute
  • 11.3. Clinical Diagnostic Laboratory
  • 11.4. Contract Research Organization
  • 11.5. Pharmaceutical & Biotechnology Companies

12. Mutation Detection Kits In Genome Editing Market, by Distribution Channel

  • 12.1. Introduction
  • 12.2. Direct Sale
  • 12.3. Distributor
  • 12.4. Online Distribution

13. Mutation Detection Kits In Genome Editing Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. Europe
  • 13.3. North America
  • 13.4. Latin America
  • 13.5. Africa
  • 13.6. Middle East

14. Mutation Detection Kits In Genome Editing Market, by Group

  • 14.1. NATO
  • 14.2. G7
  • 14.3. BRICS
  • 14.4. European Union
  • 14.5. ASEAN
  • 14.6. GCC

15. Mutation Detection Kits In Genome Editing Market, by Country

  • 15.1. China
  • 15.2. United States
  • 15.3. Japan
  • 15.4. India
  • 15.5. Germany
  • 15.6. United Kingdom
  • 15.7. Australia
  • 15.8. France
  • 15.9. South Korea
  • 15.10. Italy
  • 15.11. Canada
  • 15.12. Russia
  • 15.13. Brazil
  • 15.14. Mexico
  • 15.15. Spain

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. FPNV Positioning Matrix, 2025
  • 16.3. Market Concentration Analysis, 2025
    • 16.3.1. Concentration Ratio (CR)
    • 16.3.2. Herfindahl Hirschman Index (HHI)
  • 16.4. Recent Developments & Impact Analysis, 2025
  • 16.5. Product Portfolio Analysis, 2025
  • 16.6. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. 3B BlackBio Dx Limited
  • 17.2. Agilent Technologies, Inc.
  • 17.3. Amoy Diagnostics Co., Ltd.
  • 17.4. Applied Biological Materials, Inc.
  • 17.5. Bio-Rad Laboratories Inc.
  • 17.6. Bioneer Corporation
  • 17.7. Cell Signaling Technology, Inc.
  • 17.8. Cellecta, Inc.
  • 17.9. Danaher Corporation
  • 17.10. F. Hoffmann-La Roche Ltd.
  • 17.11. GenScript Biotech Corporation
  • 17.12. Illumina, Inc.
  • 17.13. Lonza Group AG
  • 17.14. Medaysis Company
  • 17.15. Merck KGaA
  • 17.16. Mylab Discovery Solutions
  • 17.17. New England Biolabs, Inc.
  • 17.18. Origene Technologies, Inc.
  • 17.19. Paragon Genomics, Inc.
  • 17.20. Promega Corporation
  • 17.21. Qiagen N.V.
  • 17.22. Revvity Inc.
  • 17.23. Synthego Corporation
  • 17.24. Takara Bio Inc.
  • 17.25. Thermo Fisher Scientific Inc.
  • 17.26. TransGen Biotech Co., Ltd.
  • 17.27. Vazyme Biotech Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 25. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MUTATION DETECTION KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MUTATION DETECTION KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MUTATION DETECTION KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ASSAY PANELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ASSAY PANELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ASSAY PANELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SOFTWARE & BIOINFORMATICS TOOLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SOFTWARE & BIOINFORMATICS TOOLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SOFTWARE & BIOINFORMATICS TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HIGH RESOLUTION MELT ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HIGH RESOLUTION MELT ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HIGH RESOLUTION MELT ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEXT-GENERATION SEQUENCING (NGS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NEXT-GENERATION SEQUENCING (NGS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEXT-GENERATION SEQUENCING (NGS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DIGITAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DIGITAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DIGITAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL END POINT PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL END POINT PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL END POINT PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL REAL TIME PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL REAL TIME PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL REAL TIME PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RESTRICTION FRAGMENT LENGTH POLYMORPHISM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RESTRICTION FRAGMENT LENGTH POLYMORPHISM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RESTRICTION FRAGMENT LENGTH POLYMORPHISM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SANGER SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SANGER SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SANGER SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DATA ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DATA ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DATA ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL POST EDITING VALIDATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL POST EDITING VALIDATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL POST EDITING VALIDATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PRE EDITING QUALITY CONTROL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PRE EDITING QUALITY CONTROL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PRE EDITING QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BASIC RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BASIC RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BASIC RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DRUG DISCOVERY & TARGET VALIDATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DRUG DISCOVERY & TARGET VALIDATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DRUG DISCOVERY & TARGET VALIDATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CELL LINE ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CELL LINE ENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CELL LINE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL THERAPEUTIC DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL THERAPEUTIC DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL THERAPEUTIC DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ACADEMIC AND RESEARCH INSTITUTE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ACADEMIC AND RESEARCH INSTITUTE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ACADEMIC AND RESEARCH INSTITUTE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CLINICAL DIAGNOSTIC LABORATORY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CLINICAL DIAGNOSTIC LABORATORY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CLINICAL DIAGNOSTIC LABORATORY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DIRECT SALE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL DIRECT SALE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL DIRECT SALE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL DISTRIBUTOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL DISTRIBUTOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL DISTRIBUTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ONLINE DISTRIBUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ONLINE DISTRIBUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ONLINE DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. NATO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. NATO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 151. NATO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. NATO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2032 (USD MILLION)
  • TABLE 153. NATO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 154. NATO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. NATO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. NATO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. G7 MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. G7 MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 159. G7 MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. G7 MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2032 (USD MILLION)
  • TABLE 161. G7 MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 162. G7 MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. G7 MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. G7 MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2032 (USD MILLION)
  • TABLE 169. BRICS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. GCC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 190. GCC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 191. GCC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. GCC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2032 (USD MILLION)
  • TABLE 193. GCC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 194. GCC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. GCC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. GCC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2032 (USD MILLION)
  • TABLE 202. CHINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. JAPAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. JAPAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 216. JAPAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. JAPAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2032 (USD MILLION)
  • TABLE 218. JAPAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 219. JAPAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. JAPAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. JAPAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 222. INDIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 223. INDIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 224. INDIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. INDIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2032 (USD MILLION)
  • TABLE 226. INDIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 227. INDIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. INDIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. INDIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. GERMANY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 231. GERMANY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 232. GERMANY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 233. GERMANY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2032 (USD MILLION)
  • TABLE 234. GERMANY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 235. GERMANY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. GERMANY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. GERMANY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED KINGDOM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED KINGDOM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED KINGDOM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED KINGDOM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2032 (USD MILLION)
  • TABLE 242. UNITED KINGDOM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED KINGDOM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED KINGDOM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED KINGDOM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. AUSTRALIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. AUSTRALIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 248. AUSTRALIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 249. AUSTRALIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2032 (USD MILLION)
  • TABLE 250. AUSTRALIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 251. AUSTRALIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. AUSTRALIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. AUSTRALIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 254. FRANCE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 255. FRANCE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 256. FRANCE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. FRANCE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2032 (USD MILLION)
  • TABLE 258. FRANCE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 259. FRANCE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 260. FRANCE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. FRANCE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 262. SOUTH KOREA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. SOUTH KOREA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 264. SOUTH KOREA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 265. SOUTH KOREA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2032 (USD MILLION)
  • TABLE 266. SOUTH KOREA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 267. SOUTH KOREA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 268. SOUTH KOREA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. SOUTH KOREA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 270. ITALY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 271. ITALY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 272. ITALY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 273. ITALY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2032 (USD MILLION)
  • TABLE 274. ITALY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 275. ITALY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. ITALY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. ITALY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 278. CANADA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 279. CANADA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 280. CANADA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 281. CANADA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2032 (USD MILLION)
  • TABLE 282. CANADA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 283. CANADA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 284. CANADA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. CANADA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 286. RUSSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. RUSSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 288. RUSSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 289. RUSSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2032 (USD MILLION)
  • TABLE 290. RUSSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 291. RUSSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 292. RUSSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 293. RUSSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 294. BRAZIL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 295. BRAZIL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 296. BRAZIL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 297. BRAZIL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2032 (USD MILLION)
  • TABLE 298. BRAZIL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 299. BRAZIL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 300. BRAZIL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 301. BRAZIL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 302. MEXICO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 303. MEXICO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY OFFERING, 2018-2032 (USD